Pulse Biosciences (PLSE) Long-Term Debt Issuances (2021)
Pulse Biosciences (PLSE) recorded quarterly Long-Term Debt Issuances of -$1.9 million in Q4 2021, down 1027.75% quarter-over-quarter from $209000.0 in Q3 2021.
Pulse Biosciences (PLSE) Long-Term Debt Issuances (2021) Analysis & Trends
Pulse Biosciences' Long-Term Debt Issuances history runs 1 years deep, the most recent figure standing at -$1.9 million for Q4 2021.
- In Q4 2021, Long-Term Debt Issuances changed N/A year-over-year to -$1.9 million; the TTM figure through Dec 2023 stood at -$1.7 million (up 95.78% YoY), while the FY2022 annual figure was $65.0 million, changed N/A from the prior year.
- Long-Term Debt Issuances was -$1.9 million for Q4 2021 at Pulse Biosciences, down from $209000.0 in the prior quarter.
- In the past five years, Long-Term Debt Issuances ranged from a high of $41.0 million in Q1 2021 to a low of -$39.3 million in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Issuance (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | - |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 46.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 857.70 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | - |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | - |
| 10 | Pulse Biosciences | 1.68 Bn | 1.68 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -1.94 Mn |
| Dec 31, 2021 | -1.94 Mn |
| Sep 30, 2021 | 209,000.00 |
| Sep 30, 2021 | 209,000.00 |
| Jun 30, 2021 | -39.27 Mn |
| Jun 30, 2021 | -39.27 Mn |
| Mar 31, 2021 | 41.00 Mn |
| Mar 31, 2021 | 41.00 Mn |